tirzepatide oral formulation Tirzepatide: Dual-Incretin GLP-1 in a Daily Tablet the dual Tirzepatide oral vs injection: which

"In fact, the big studies coming out are telling us that [after taking one of these medications] for about a year to a year-and-a-half, people are achieving about 15% to 20% weight loss." Additionally, patients are seeing improved liver function and lower rates of stroke as well as kidney and heart disease

Hence, those in the GLP-1 cohort had around a 26% higher risk of developing erectile dysfunction over the 3-year follow-up period

2 Effects of GLP-1RA/Tesaglitazar relative to GLP-1RA + Tesaglitazar co-therapy

Myth: weight loss always causes ED While extreme caloric restriction can temporarily suppress testosterone, moderate sustained weight loss consistently improves erectile function